aid: rgenix
name: Rgenix
description: 'Rgenix, Inc. is a clinical-stage biopharmaceutical company founded by scientists from
  The Rockefeller University to discover and develop first-in-class small molecules and biologics
  against previously undruggable drivers of cancer metastasis, using its proprietary RNA-DRIVEr
  target-discovery platform. Its programs include ompenaclid (RGX-202), an oral SLC6A8/creatine-transporter
  inhibitor in Phase 2 for RAS-mutant colorectal cancer, abequolixron (RGX-104), an oral LXR agonist
  in Phase 1b/2, and RGX-019-MMAE, a MERTK-targeting antibody-drug conjugate. The company changed its
  corporate name from Rgenix to Inspirna in September 2021 and operates from Long Island City, New York.
  It is a therapeutics developer with no public API, developer program, or machine-readable interface.'
url: https://raw.githubusercontent.com/api-evangelist/rgenix/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-harvest-source-url: https://forgeglobal.com/rgenix_stock/
x-former-name: Rgenix, Inc.
x-current-name: Inspirna, Inc.
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Drug Discovery
- Clinical Trials
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/rgenix-domain-security.yml
- type: Website
  url: https://inspirna.com/
- type: PrivacyPolicy
  url: https://inspirna.com/privacy-policy/
- type: TermsOfService
  url: https://inspirna.com/terms-of-use/
x-enrichment:
  date: '2026-08-26'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Rgenix is a clinical-stage oncology drug developer that renamed itself Inspirna in
    September 2021; rgenix.com now 301s to an unresponsive www.rgenix.com, and the live corporate
    site inspirna.com is a WordPress marketing site (company/science/pipeline/patients/careers/news)
    with no developer section, no GitHub organization, and a 404 on every contract-discovery path.
  evidence:
  - url: https://inspirna.com/openapi.json
    status: 404
  - url: https://inspirna.com/.well-known/agent-card.json
    status: 404
  - url: https://api.github.com/orgs/inspirna
    status: 404
  - url: http://rgenix.com/
    status: 301
  checked: '2026-08-26'